D. Ware Branch
( out of 21 reviews )

D. Ware Branch, MD

Languages spoken: English

Clinical Locations

South Jordan Health Center

South Jordan
801-213-4500

Sugar House Health Center

Salt Lake City
801-581-2000

University of Utah Hospital

University Maternal Fetal Medicine, Area E
Salt Lake City
801-213-2995

  • Dr. Ware Branch has a passion for helping those who face complex pregnancy challenges and cares for his patients experiencing high-risk pregnancies. As a specialist in maternal-fetal medicine, Dr. Branch specializes in managing various conditions, including recurrent miscarriage, genetics and fetal diagnosis, placenta accreta, and stillbirth. He is committed to achieving the best possible outcomes for his patients and is here to support you and your family every step of the way through your pregnancy journey.

    Dr. Branch is currently accepting new patients. Please call to schedule an appointment or for more information.

    Dr. Branch has been dedicated to high-risk pregnancies since 1985, when he completed his fellowship in maternal-fetal medicine at the University of Utah and completed specialty training.

    He now leads the fellowship program, passing on his knowledge and experience to the next generation of doctors. He is also a professor of obstetrics and gynecology at the Spencer Fox Eccles School of Medicine at the University of Utah and serves as the medical director of the women and newborn clinical program for the urban central region of Intermountain Health.

    Dr. Branch is internationally recognized for his research and expertise in managing conditions like antiphospholipid syndrome (APS), thrombotic disorders during pregnancy, and recurrent pregnancy loss.

    Specialties

    Board Certification

    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)
    American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)

    Patient Rating

    4.2 /5
    ( out of 21 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 18, 2024
    SOUTH JORDAN HEALTH CENTER

    Dr.Branch really cares about your success and wants the best for you! He's really great!

    October 18, 2024
    SOUTH JORDAN HEALTH CENTER

    Dr Branch is very nice and caring. He truely was concern for us.

    June 08, 2024
    SUGAR HOUSE HEALTH CENTER

    I feel confident in the care I receive from Dr. Branch. He is detailed in answering my questions and straightforward. I know he is a very busy provider, but he never makes me feel rushed during the appointments. I'm fortunate that he has been my provider for both my pregnancies. Thank you Dr. Branch for all you do for the T1D community!!

    May 26, 2024
    UH HOSPITALS AND CLINICS

    Dr. Branch is amazing! I would highly recommend him. I trust him to provide me with the best care!

    May 01, 2024
    UH HOSPITALS AND CLINICS

    Dr Branch had a positive vibe which made me comfortable to share my health concerns. He is a great communicator.

    April 21, 2024
    SOUTH JORDAN HEALTH CENTER

    He is a great doctor. Very good at his job. But continues to treat me like a child. He calls me "kid" everytime I see him. He also continues to lecture me on my eating habits, drinking coffee, working out, etc.

    April 04, 2024
    UH HOSPITALS AND CLINICS

    Dr.Branch is very professional and attentive. He answers all questions and gives clear instructions.

    March 27, 2024
    UH HOSPITALS AND CLINICS

    He took the time to explain things that doctors I. The past had not. He seemed calm and not rushed. He answered all our questions and his answers were all research based. He was warm and compassionate as well.

    February 24, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr Branch makes sure your questions and concerns are addressed. He is a dr with zero filter and that's exactly what I wanted, to make sure I'm 100% aware of what can do to make sure my pregnancy and baby are healthy.

    See More Patient Comments

  • Dr. Ware Branch has a passion for helping those who face complex pregnancy challenges and cares for his patients experiencing high-risk pregnancies. As a specialist in maternal-fetal medicine, Dr. Branch specializes in managing various conditions, including recurrent miscarriage, genetics and fetal diagnosis, placenta accreta, and stillbirth. He is committed to achieving the best possible outcomes for his patients and is here to support you and your family every step of the way through your pregnancy journey.

    Dr. Branch is currently accepting new patients. Please call to schedule an appointment or for more information.

    Dr. Branch has been dedicated to high-risk pregnancies since 1985, when he completed his fellowship in maternal-fetal medicine at the University of Utah and completed specialty training.

    He now leads the fellowship program, passing on his knowledge and experience to the next generation of doctors. He is also a professor of obstetrics and gynecology at the Spencer Fox Eccles School of Medicine at the University of Utah and serves as the medical director of the women and newborn clinical program for the urban central region of Intermountain Health.

    Dr. Branch is internationally recognized for his research and expertise in managing conditions like antiphospholipid syndrome (APS), thrombotic disorders during pregnancy, and recurrent pregnancy loss.

    Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Primary
    Academic Divisions Maternal Fetal Medicine
    Board Certification
    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)
    American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)

    Education history

    Fellowship Maternal/Fetal Medicine - University of Utah School of Medicine Fellow
    OB/GYN - Medical College of Virginia Hospital Resident
    Internship OB/GYN - Medical College of Virginia Hosp. Intern
    Medicine - Medical College of Virginia M.D.
    Undergraduate Biology - University of Richmond B.S.

    Selected Publications

    Journal Article

    1. Yelnik CM, Erton ZB, Drumez E, Cheildze D, de Andrade D, Clarke A, Tektonidou MG, Sciascia S, Pardos-Gea J, Pengo V, Ruiz-Irastorza G, Belmont HM, Pedrera CL, Fortin PR, Wahl D, Gerosa M, Kello N, Signorelli F, Atsumi T, Ji L, Efthymiou M, Branch DW, Nalli C, Rodriguez-Almaraz E, Petri M, Cervera R, Shi H, Zuo Y, Artim-Esen B, Pons-Estel G, Willis R, Barber MRW, Skeith L, Bertolaccini ML, Cohen H, Roubey R, Erkan D (2023). Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry"). Semin Arthritis Rheum, 65, 152347. (Read full article)
    2. Lim MY, Rodgers GM, Branch DW, Simonsen SE (2024). Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single-institution cohort study. Haemophilia, 30(2), 470-477. (Read full article)
    3. Branch DW, Lim MY (2023). How I diagnose and treat antiphospholipid syndrome in pregnancy. Blood, 143(9), 757-768. (Read full article)
    4. Zhu H, Lu D, Branch DW, Troendle J, Tang Y, Bernitz S, Zamora J, Betran AP, Zhou Y, Zhang J (2023). Oxytocin is not associated with postpartum hemorrhage in labor augmentation in a retrospective cohort study in the United States. Am J Obstet Gynecol, 230(2), 247.e1-247.e9. (Read full article)
    5. Bruno AM, Allshouse AA, Benson AE, Yost CC, Metz TD, Varner MW, Silver RM, Branch DW (2023). Thrombotic Markers in Pregnant Patients with and without SARS-CoV-2 Infection. Am J Perinatol. (Read full article)
    6. Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesus G, Delluc A, Desai S, De Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-Garcia A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D, ACREULAR APS Classification Criteria Collaborators (2023). The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol, 75(10), 1687-1702. (Read full article)
    7. Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jess G, Delluc A, Desai S, Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-Garca A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D, ACREULAR APS Classification Criteria Collaborators (2023). 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis, 82(10), 1258-1270. (Read full article)
    8. Parks AL, Fazili M, Aston V, Porter TF, Branch DW, Woller SC, Snow GL, Stevens SM (2023). Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasound. Res Pract Thromb Haemost, 7(7), 102202. (Read full article)
    9. Zuo Y, Navaz S, Tsodikov A, Kmetova K, Kluge L, Ambati A, Hoy CK, Yalavarthi S, de Andrade D, Tektonidou MG, Sciascia S, Pengo V, Ruiz-Irastorza G, Belmont HM, Gerosa M, Fortin PR, de Jesus GR, Branch DW, Andreoli L, Rodriguez-Almaraz E, Petri M, Cervera R, Willis R, Karp DR, Li QZ, Cohen H, Bertolaccini ML, Erkan D, Knight JS, Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (2023). Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository. Arthritis Rheumatol, 75(8), 1407-1414. (Read full article)
    10. Branch DW, VanBuren JM, Porter TF, Holmgren C, Holubkov R, Page K, Burchard J, Lam GK, Esplin MS (2021). Prediction and Prevention of Preterm Birth: A Prospective, Randomized Intervention Trial. Am J Perinatol, 40(10), 1071-1080. (Read full article)
    11. Balbi GGM, Ahmadzadeh Y, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Lopez-Pedrera C, Fortin PR, Wahl D, Gerosa M, de Jess GR, Ji L, Atsumi T, Efthymiou M, Branch DW, Nalli C, Almaraz ER, Petri M, Cervera R, Knight JS, Artim-Esen B, Willis R, Bertolaccini ML, Cohen H, Roubey R, Erkan D, Andrade D, AntiPhospholipid Syndrome Alliance for Clinical Trials and International Networking APS ACTION Clinical Database and Repository APS ACTION (2023). Damage measured by damage index for antiphosphlipid syndrome in antiphospholipid antibody-positive patients included in APS ACTION Registry. Rheumatology (Oxford). (Read full article)
    12. Chighizola CB, Pregnolato F, Andrade D, Tektonidou M, Pengo V, Ruiz-Irastorza G, Belmont HM, Gerosa M, Fortin P, Branch DW, Andreoli L, Petri MA, Cervera R, Knight JS, Willis R, Efthymiou M, Cohen H, Erkan D, Bertolaccini ML, Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking APS ACTION (2023). Fluctuation of Anti-Domain 1 and Anti-β(2) -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies. Arthritis Rheumatol, 75(6), 984-995. (Read full article)
    13. Gkrouzman E, Willis R, Andrade D, Tektonidou MG, Pengo V, Ruiz-Irastorza G, Belmont HM, Fortin PR, Gerosa M, Signorelli F, Atsumi T, Branch DW, Nalli C, Rodriguez-Almaraz E, Petri MA, Cervera R, Knight JS, Efthymiou M, Cohen H, Bertolaccini ML, Erkan D, Roubey R, APS ACTION (2023). Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study. Lab Invest, 103(6), 100147. (Read full article)
    14. Dude AM, Smid MC, Branch DW, West J, Meeks H, Yu Z, Fraser A, Smith K, Reddy D (2021). Interpregnancy Body Mass Index Change and Offspring Mortality Risk following the Second Pregnancy. Am J Perinatol, 40(4), 387-393. (Read full article)
    15. Einerson BD, Kennedy A, Silver RM, Branch DW, Comstock J, Woodward PJ (2023). Ultrasonography of the Explanted Uterus in Placenta Accreta Spectrum: Correlation With Intraoperative Findings and Gross Pathology. Obstet Gynecol, 141(3), 544-554. (Read full article)
    16. Workalemahu T, Avery C, Lopez S, Blue NR, Wallace A, Quinlan AR, Coon H, Warner D, Varner MW, Branch DW, Jorde LB, Silver RM (2023). Whole-genome sequencing analysis in families with recurrent pregnancy loss: A pilot study. PLoS One, 18(2), e0281934. (Read full article)
    17. Mehta B, Jannat-Khah D, Glaser KK, Luo Y, Sammaritano LR, Branch DW, Goodman SM, Lockshin M, Wang F, Ibrahim S, Salmon JE (2022). Fetal and maternal morbidity in pregnant patients with Lupus: a 10-year US nationwide analysis. RMD Open, 9(1). (Read full article)
    18. Young A, Lim MY, Sanders J, Branch DW, Simonsen SE (2022). Pregnancy and childbirth in women with bleeding disorders: A retrospective cohort study. Haemophilia, 29(1), 240-247. (Read full article)
    19. Lim MY, Abou-Ismail MY, Branch DW (2022). Differentiating and Managing Rare Thrombotic Microangiopathies During Pregnancy and Postpartum. Obstet Gynecol, 141(1), 85-108. (Read full article)
    20. Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, Branch DW, Maurer KA, Dood RL, Debbink MP, Silver RM, Einerson BD (2022). Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstet Gynecol, 140(5), 806-811. (Read full article)
    21. Bruno AM, Allshouse AA, Campbell HM, Branch DW, Lim MY, Silver RM, Metz TD (2022). Weight-Based Compared With Fixed-Dose Enoxaparin Prophylaxis After Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol, 140(4), 575-583. (Read full article)
    22. Erton ZB, Sevim E, de Jess GR, Cervera R, Ji L, Pengo V, Ugarte A, Andrade D, Andreoli L, Atsumi T, Fortin PR, Gerosa M, Zuo Y, Petri M, Sciascia S, Tektonidou MG, Aguirre-Zamorano MA, Branch DW, Erkan D, APS ACTION (2021). Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry'). Lupus Sci Med, 9(1). (Read full article)
    23. Woller SC, Stevens SM, Kaplan D, Wang TF, Branch DW, Groat D, Wilson EL, Armbruster B, Aston VT, Lloyd JF, Rondina MT, Elliott CG (2021). Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood Adv, 6(6), 1661-1670. (Read full article)
    24. Givens M, Einerson BD, Allshouse AA, Bruno AM, Hammad I, Debbink MP, Branch DW, Silver RM (2021). Trends in Unplanned Peripartum Hysterectomy in the United States, 2009-2020. Obstet Gynecol, 139(3), 449-451. (Read full article)
    25. Sevim E, Zisa D, Andrade D, Sciascia S, Pengo V, Tektonidou MG, Ugarte A, Gerosa M, Belmont HM, Zamorano MAA, Fortin PR, Ji L, Efthymiou M, Cohen H, Branch DW, de Jesus GR, Andreoli L, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Roubey R, Bertolaccini ML, Erkan D, Barbhaiya M, APS ACTION Investigators (2020). Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository. Arthritis Care Res (Hoboken), 74(2), 324-335. (Read full article)
    26. Arslan E, Einerson BD, Zhang J, Zhang J, Branch DW (2021). The Effect of "Off Hours" on Maternal and Perinatal Outcomes in a Diverse U.S. Cohort. Am J Perinatol, 41(1), 89-97. (Read full article)
    27. de Azevedo Lopes E, Balbi GGM, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Gerosa M, Fortin PR, Lopez-Pedrera C, Ji L, Cohen H, de Jess GR, Branch DW, Nalli C, Petri M, Rodriguez E, Kello N, Ros-Garcs R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Erkan D, Andrade D, APS ACTION (2021). Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository. Adv Rheumatol, 61(1), 64. (Read full article)
    28. Gkrouzman E, Sevim E, Finik J, Andrade D, Pengo V, Sciascia S, Tektonidou MG, Ugarte A, Chighizola CB, Belmont HM, Lopez-Pedrera C, Ji L, Fortin P, Efthymiou M, de Jesus GR, Branch DW, Nalli C, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Cohen H, Rand J, Erkan D, APS ACTION (2020). Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository. J Rheumatol, 48(4), 541-547. (Read full article)
    29. Carey AZ, Blue NR, Varner MW, Page JM, Chaiyakunapruk N, Quinlan AR, Branch DW, Silver RM, Workalemahu T (2021). A systematic review to guide future efforts in the determination of genetic causes of pregnancy loss. Front Reprod Health, 3. (Read full article)
    30. Paidas MJ, Tita ATN, Macones GA, Saade GA, Ehrenkranz RA, Triche EW, Streisand JB, Lam GK, Magann EF, Lewis DF, Dombrowski MP, Werner EF, Branch DW, Habli MA, Grotegut CA, Silver RM, Longo SA, Amon E, Cleary KL, How HY, Novotny SR, Grobman WA, Whiteman VE, Wing DA, Scifres CM, Sibai BM (2020). Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia. Am J Obstet Gynecol, 223(5), 739.e1-739.e13. (Read full article)
    31. Zuily S, Clerc-Urms I, Bauman C, Andrade D, Sciascia S, Pengo V, Tektonidou MG, Ugarte A, Gerosa M, Michael Belmont H, Zamorano MAA, Fortin P, Ji L, Efthymiou M, Cohen H, Branch DW, Jesus GR, Nalli C, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Vega J, Wahl D, Erkan D, APS ACTION Investigators (2020). Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry. Lupus, 29(11), 1353-1363. (Read full article)

    Review

    1. Chighizola CB, Willis R, Maioli G, Sciascia S, Andreoli L, Amengual O, Radin M, Gerosa M, Atsumi T, de Jesus G, Trespidi L, Branch DW, Caporali R, Andrade D, Roubey R, Petri M, Bertolaccini ML (2024). Deciphering the clinical significance of longitudinal antiphospholipid antibody titers. [Review]. Autoimmun Rev, 23(3), 103510. (Read full article)
    2. Knight JS, Branch DW, Ortel TL (2023). Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. [Review]. BMJ, 380, e069717. (Read full article)
    3. Barbhaiya M, Zuily S, Ahmadzadeh Y, Amigo MC, Avcin T, Bertolaccini ML, Branch DW, de Jesus G, Devreese KMJ, Frances C, Garcia D, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Seshan SV, Tektonidou M, Wahl D, Willis R, Naden R, Costenbader K, Erkan D, New APS Classification Criteria Collaborators (2021). Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria. [Review]. Arthritis Care Res (Hoboken), 73(10), 1490-1501. (Read full article)
    4. de Jess GR, Benson AE, Chighizola CB, Sciascia S, Branch DW (2020). 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome. [Review]. Lupus, 29(12), 1601-1615. (Read full article)
    5. Welsch S, Branch DW (1997). Antiphospholipid syndrome in pregnancy. Obstetric concerns and treatment. [Review]. Rheum Dis Clin North Am, 23(1), 71-84. (Read full article)

    Commentary

    1. Shainker SA, Silver RM, Modest AM, Hacker MR, Hecht JL, Salahuddin S, Dillon ST, Ciampa EJ, DAlton ME, Otu HH, Abuhamad AZ, Einerson BD, Branch DW, Wylie BJ, Libermann TA, Karumanchi SA (2020). Placenta accreta spectrum: biomarker discovery using plasma proteomics. Am J Obstet Gynecol, 223(3), 433.e1-433.e14. (Read full article)
    2. Einerson BD, Comstock J, Silver RM, Branch DW, Woodward PJ, Kennedy A (2020). In Reply. Obstet Gynecol, 136(3), 632. (Read full article)
    3. Einerson BD, Nelson RE, Sandoval G, Esplin MS, Branch DW, Metz TD, Silver RM, Grobman WA, Reddy UM, Varner M, Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2020). Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women. Obstet Gynecol, 136(1), 19-25. (Read full article)
    4. Einerson BD, Comstock J, Silver RM, Branch DW, Woodward PJ, Kennedy A (2020). Placenta Accreta Spectrum Disorder: Uterine Dehiscence, Not Placental Invasion. Obstet Gynecol, 135(5), 1104-1111. (Read full article)
    5. Arslan E, Branch DW (2019). Antiphospholipid syndrome: Diagnosis and management in the obstetric patient. Best Pract Res Clin Obstet Gynaecol, 64, 31-40. (Read full article)
    6. Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, DAnci KE (2020). 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken), 72(4), 461-488. (Read full article)
    7. Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, DAnci KE (2020). 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol, 72(4), 529-556. (Read full article)
    8. Davis-Porada J, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Sawitzke A, Merrill JT, Buyon JP, Salmon JE (2020). Low frequency of flares during pregnancy and post-partum in stable lupus patients. Arthritis Res Ther, 22(1), 52. (Read full article)
    9. Branch DW (2019). What's new in obstetric antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program, 2019(1), 421-425. (Read full article)
    10. Radin M, Sciascia S, Erkan D, Pengo V, Tektonidou MG, Ugarte A, Meroni P, Ji L, Belmont HM, Cohen H, Ramires de Jess G, Branch DW, Fortin PR, Andreoli L, Petri M, Rodriguez E, Rodriguez-Pinto I, Knight JS, Atsumi T, Willis R, Gonzalez E, Lopez-Pedrera R, Rossi Gandara AP, Borges Gualhardo Vendramini M, Banzato A, Sevim E, Barbhaiya M, Efthymiou M, Mackie I, Bertolaccini ML, Andrade D, APS ACTION (2019). The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort. Semin Arthritis Rheum, 49(3), 464-468. (Read full article)
    11. Efthymiou M, Mackie IJ, Lane PJ, Andrade D, Willis R, Erkan D, Sciascia S, Krillis S, Bison E, Borges Galhardo Vendramini M, Romay-Penabad Z, Qi M, Tektonidou M, Ugarte A, Chighizola C, Belmont HM, Aguirre MA, Ji L, Branch DW, de Jesus G, Fortin PR, Andreoli L, Petri M, Cervera R, Rodriguez E, Knight JS, Atsumi T, Vega J, Sevim E, Bertolaccini ML, Pengo V, Cohen H, APS ACTION (2019). Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository. J Thromb Haemost, 17(12), 2069-2080. (Read full article)
    12. Odendaal J, Quenby S, Sammaritano L, Macklon N, Branch DW, Rosenwaks Z (2019). Immunologic and rheumatologic causes and treatment of recurrent pregnancy loss: what is the evidence? Fertil Steril, 112(6), 1002-1012. (Read full article)
    13. Hong S, Banchereau R, Maslow BL, Guerra MM, Cardenas J, Baisch J, Branch DW, Porter TF, Sawitzke A, Laskin CA, Buyon JP, Merrill J, Sammaritano LR, Petri M, Gatewood E, Cepika AM, Ohouo M, Obermoser G, Anguiano E, Kim TW, Nulsen J, Nehar-Belaid D, Blankenship D, Turner J, Banchereau J, Salmon JE, Pascual V (2019). Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy. J Exp Med, 216(5), 1154-1169. (Read full article)
    14. de Jess GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, Pengo V, Ji L, Meroni PL, Ugarte A, Cohen H, Branch DW, Andreoli L, Belmont HM, Fortin PR, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Nascimento IS, Rosa R, Erkan D, Levy RA, APS ACTION (2018). Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study. BJOG, 126(5), 656-661. (Read full article)
    15. Sciascia S, Willis R, Pengo V, Krilis S, Andrade D, Tektonidou MG, Ugarte A, Chighizola C, Branch DW, Levy RA, Nalli C, Fortin PR, Petri M, Rodriguez E, Rodriguez-Pinto I, Atsumi T, Nascimento I, Rosa R, Banzato A, Erkan D, Cohen H, Efthymiou M, Mackie I, Bertolaccini ML, APS ACTION (2019). The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis. Thromb Res, 175, 32-36. (Read full article)
    16. Einerson BD, Branch DW (2018). Surgical Management of Placenta Accreta Spectrum. Clin Obstet Gynecol, 61(4), 774-782. (Read full article)
    17. Zhang L, Troendle J, Branch DW, Hoffman M, Yu J, Zhou L, Duan T, Zhang J (2018). The expected labor progression after labor augmentation with oxytocin: A retrospective cohort study. PLoS One, 13(10), e0205735. (Read full article)
    18. Tebo AE, Willis R, Jaskowski TD, Guerra M, Pierangeli SS, Salmon J, Petri M, Branch DW (2016). Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus. Clin Chim Acta, 460, 107-13. (Read full article)

    Letter

    1. Barbhaiya M, Zuily S, de Jesus G, Branch DW, Erkan D (2024). Reply. [Letter to the editor]. Arthritis Rheumatol. (Read full article)
    2. Bruno AM, Allshouse AA, Einerson BD, Campbell HM, Branch DW, Silver RM, Metz TD (2022). Trends in postpartum venous thromboembolism and chemical prophylaxis among insured US patients. [Letter to the editor]. Am J Obstet Gynecol MFM, 4(4), 100620. (Read full article)
    3. Harris EN, Goldsmith G, Pierangeli S, Gharavi A, Branch W (1995). Phospholipid binding antibodies warrant continued investigation. [Letter to the editor]. Blood, 85(8), 2276-7. (Read full article)

  • News & Podcasts

    News